laboratory expansion at STERIS tullamore, ireland facility  

June 12, 2020

Mark Botting, Director, Global Laboratories. 

June 2020 - Earlier this year, we celebrated the official opening of the expanded laboratory at the STERIS Tullamore, Ireland facility. The laboratory expansion complements the existing electron beam and ethylene oxide sterilization services offered at the Tullamore facility.

The occasion was marked by the attendance of a large number of Irish medical device and pharmaceutical manufacturers, plus representatives from the local council, Irish agencies and suppliers involved in the project.

Visitors were joined by STERIS Tullamore employees and members of the STERIS leadership team for an opening ceremony and tour of the facilities.

The event marked the culmination of four years' hard work to deliver a laboratory space that not only meets current needs, but has scope for continued growth of our sterilization offering to meet the needs of our valued Customers.

Lorraine Moran, Ireland Regional Director, comments that the “STERIS plan is to continue to always be at the forefront of sterilization innovation and delivery”.

The expansion includes a new state-of-the-art laboratory, double the size of the previous laboratory, improved process flow, and adding a new cleanroom suite to support the growth in volume and increased complexity of medical devices.

Mark Botting, Director of Global Laboratories at STERIS Applied Sterilization Technologies, outlines, “The team has done an excellent job in delivering this new laboratory, which will allow us to further improve the great service we give to our Customers, and supports our ongoing commitment to expanding capacity and service to the Irish market place.”

2020.02-Tullamore-Opening-building-200px

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. For more information, visit www.steris.com.

 
Related Posts
202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.
STERIS is pleased to announce our brooklyn park mn usa laboratory iso 17025 accreditation now incl
November 21, 2024
November 21, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory ISO 17025 accreditation now includes product and package testing services.